In view of the narrow window of opportunity, we considered time to market to be critical. With their outstanding cross-sector expertise, Zuhlke provided us with crucial support in rapidly adapting our product for the pharmaceutical industry.
Counterfeit medicines are harmful to the economy and health Globally, around 10% of medicines are counterfeit. Legislators have introduced new labelling legislation aimed at making medicines traceable and harder to counterfeit by 2019. In response, the banknote serialisation specialist hit upon the clever idea of applying its existing expertise to the pharmaceutical sector.
Time was pressing. Any company that could deliver a future-proof system for the pharmaceutical sector now would have a clear head start over the competition. To utilise the narrow window of opportunity, Zuhlke and G+D Currency Technology put together an interdisciplinary team which, working under strong time pressure, used an agile development process to adapt an existing software solution for use in the pharmaceutical sector.
The SeriTrack Pharma system generates an individual ID based on the product code, serial number, batch number and expiry date. This information is applied to the packaging during manufacture as a QR code and synchronized with national verification systems. From the initial idea to the first installation at a pharmaceutical manufacturer took less than 12 months.
Director Solution Center